Omnipure

OmniPure is an Israeli biotechnology company that has developed a proprietary platform for the high-efficiency purification of biological nanoparticles, specifically exosomes and viral vectors. The company's technology addresses a major bottleneck in the production of advanced therapies by enabling the isolation of high-purity, functional biological vesicles at scale. By replacing traditional, labor-intensive methods like ultracentrifugation, OmniPure's solution aims to reduce manufacturing costs and improve the consistency of cell-derived products. The platform is designed for integration into existing biopharmaceutical workflows, supporting the development of next-generation diagnostics and therapeutics. OmniPure is currently focused on establishing partnerships with biopharma companies to validate its technology across various therapeutic modalities.